RDY

Dr Reddys Laboratories
$11.71
−$0.17 (−1.43%)Sep 10, 2026
5.2NeutralMoatMint rating

MoatMint rates Dr Reddys Laboratories (RDY) 5.2 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 7.5 out of 10.

Key metrics

The numbers that frame RDY today
Market cap
$9.77B
P/E (TTM)
21.9
EV / FCF
53.7
Gross margin
52.8%
EV / Sales
3.0
ROIC
18.4%
Div yield
0.78%
Debt / equity
0.2
52wk Low
$11.30
52wk High
$15.51

RDY stock rating

How RDY scores on quality, value, growth, momentum and financial health
5.2out of 10
Neutral overallFair business, fair price
Quality7.5
Growth3.7
Momentum2.9
Value6.7
Financial Health-

Growth

Revenue and earnings trend for RDY
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about RDY
Is Dr Reddys Laboratories a good buy?
Hold. Dr Reddys Laboratories has excellent quality, but poor momentum makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Dr Reddys Laboratories is selling at a fair price.
What is the market capitalization of RDY?
Dr Reddys Laboratories's market capitalization is $9.77B.
What is the P/E ratio for RDY stock?
Dr Reddys Laboratories's current P/E ratio is 21.9.
What is the 52-week high for RDY stock?
The 52-week high for Dr Reddys Laboratories is $15.51. The current close of $11.71 is 24.5% below that high.
What is the 52-week low for RDY stock?
The 52-week low for Dr Reddys Laboratories is $11.30. The current close of $11.71 is 3.6% above that low.
Does RDY stock pay dividends?
Dr Reddys Laboratories pays a dividend. The latest dividend per share in the company data is $0.09, which implies a yield of 0.78% based on the current close.
What is the Debt / Equity ratio for RDY?
Dr Reddys Laboratories's Debt / Equity ratio is 0.21.